Highlights Kadimastem Ltd

Equities

KDST

IL0011284614

Market Closed - TEL AVIV STOCK EXCHANGE Other stock markets 10:24:17 2024-05-07 am EDT			5-day change	1st Jan Change
472.5 ^ILa	-7.08%		-4.06%	-20.32%

Mar. 28	Kadimastem Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 28	IMC Announces Potential Reverse Merger With A Leading Clinical Cell Therapy Company	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Kadimastem Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
IMC Announces Potential Reverse Merger With A Leading Clinical Cell Therapy Company	Feb. 28	MT
Kadimastem Ltd entered into a non-binding term sheet to acquire IM Cannabis Corp. in reverse merger transaction.	Feb. 27	CI
Kadimastem Plans Listing on Nasdaq Through Merger	Feb. 18	CI
ITolerance, Inc. and Kadimastem Ltd. Submit Initial Targeted Engagement for Regulatory Advice on CBER Products	Nov. 07	CI
Kadimastem Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-31	CI
Kadimastem to Launch Clinical Trial in ALS Patients Upon Approval from the Hadassah Hospital IRB	17-06-22	CI
Kadimastem Receives Approval from the IRB (Helsinki Committee) of the Hadassah Ein Kerem Hospital for the Phase 1/2A Clinical Trial in Als Patients	17-06-21	CI
Kadimastem Announces Granting a Patent in the US for Treatment of Neurodegenerative Diseases	17-03-16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW